Cite
HARVARD Citation
Rouzade‐Dominguez, M. et al. (2017). The selective metabotropic glutamate receptor 5 antagonist mavoglurant (AFQ056) reduces the incidence of reflux episodes in dogs and patients with moderate to severe gastroesophageal reflux disease. Neurogastroenterology & motility. 29 (8), p. n/a. [Online].